Skip to main content

Depression

Researchers have developed a machine learning algorithm that uses electroencephalogram (EEG) data to predict whether a selective serotonin reuptake inhibitor (SSRI) is likely to benefit a patient.
Patients with residual depressive symptoms who received online mindfulness-based cognitive therapy (MBCT) plus usual care demonstrated significant gains in depression and functional outcomes, compared with patients who received usual care only.
Knowing someone with emotional or mental health problems increased the likelihood that people who screened positive for depression sought out depression treatment for themselves, according to a study published online in Psychiatric Services.
AXS-05, an investigational modulated-delivery tablet combining dextromethorphan and bupropion, significantly improved symptoms of depression in patients with major depressive disorder (MDD) in a recent phase 3 trial, announced developer Axsome Therapeutics Inc.
Supplemental treatment with the medical food L-methylfolate may benefit patients with depression who do not respond to antidepressants, according to a review article published online in CNS Spectrums.
Back to Top